• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [19988 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2023     Ontario Health Bariatric surgery for people with class I obesity and poorly controlled type 2 diabetes
2023     Ontario Health Testing for homologous recombination deficiency in patients diagnosed with ovarian cancer
2023     Ontario Health Wire-free, nonradioactive localization techniques to guide surgical excision of nonpalpable breast cancer tumours
2023     Ontario Health Placental growth factor (PlGF)-based biomarkers for risk prediction in people with suspected preeclampsia
2023     Norwegian Institute of Public Health (NIPH) Health technology assessment of 177Lu-PSMA 617 treatment for metastatic castration resistant prostate cancer
2023     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Home abortion]
2023     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Effects of treatment and social support measures in comorbidity]
2023     Ontario Health Supplemental breast screening for people with dense breasts
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: Hereditary Cardiovascular diseases NGS Panel - Evaluation report on the repatriation of an analysis carried out outside of the province of Québec]
2022     Austrian Institute for Health Technology Assessment (AIHTA) ATMPs and gene therapies in development. Horizon scanning – update 2022
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: update of the optimal usage guide on sexually transmitted and blood borne infections – confirmed Mycoplasma genitalium infection]
2022     NIHR Health Technology Assessment programme A pragmatic randomised controlled trial comparing the effectiveness and cost effectiveness of levetiracetam and zonisamide versus standard treatments for epilepsy: a comparison of Standard And New Antiepileptic Drugs (SANAD-II)
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: use of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for the treatment of lung cancer in the Québec context]
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: service trajectories and services for at risk or neglected children and their families]
2022     NIHR Health Technology Assessment programme SurgiCal Obesity Treatment Study (SCOTS)
2022     Health Information and Quality Authority (HIQA) High level review of configuration and reform of public health systems in selected countries
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: issues pertaining to the implementation of a clinical decision support system for diagnostic test ordering]
2022     NIHR Health Technology Assessment programme Multicentre UK study of the acetylcholinesterase inhibitor donepezil in early dementia associated with Parkinson's disease (MUSTARDD-PD)
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: needs of children at-risk or in situation of neglect and those of their family]
2022     Center for Drug Evaluation (CDE) The reimbursement coverage decisions and pricing rules for medical devices in Taiwan
2022     NIHR Health Technology Assessment programme A pragmatic randomised controlled trial and economic evaluation of family therapy vs. treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention - Family Therapy (SHIFT) trial
2022     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Promoting mental well-being in children and adolescents]
2022     Center for Evidence-based Practice (CEP) Patient bias against healthcare providers
2022     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Treatment of postpartum depression]
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Vistaseal™ – Intraoperative bleeding]
2022     NIHR Health Technology Assessment programme Plasma exchange and glucocorticoids in anti-neutrophil cytoplasm antibody associated systemic vasculitis: a randomized controlled trial. PEXIVAS
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: perineal and pelvic rehabilitation for the prevention and treatment of pelvic floor dysfunctions – Part 1: Urinary incontinence]
2022     Health Information and Quality Authority (HIQA) Catalogue of institutions undertaking COVID-19 horizon scanning
2022     Health Information and Quality Authority (HIQA) Planned public health measures and strategies to limit the impact of COVID-19 surges: an international review
2022     NIHR Health Technology Assessment programme Randomised control trial of surveillance and no surveillance for patients with Barrett's oesophagus - BOSS (Barrett's Oesophagus Surveillance Study)
2022     Ontario Health First trimester screening for risk of preeclampsia using a multiple marker algorithm
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: pharmacotherapy in the treatment of obesity]
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: optimal use of immunoglobulin in fertility, cardiology and other indications]
2022     Andalusian Health Technology Assessment Area (AETSA) Electro-hipertermia modulada en pacientes con cáncer de páncreas, cáncer colorrectal avanzado y gliomas malignos
2022     NIHR Health Technology Assessment programme Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling
2022     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Portable home hemodialysis systems]
2022     Center for Drug Evaluation (CDE) First-line treatment and overall survival in EGFR mutation-positive advanced non-small cell lung cancer: a national cohort study
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: solid organ transplantation – Section 1 - overview of heart and lung transplantation in Québec]
2022     Austrian Institute for Health Technology Assessment (AIHTA) Percutaneous coronary interventions (PCI) for chronic total occlusion (CTO). Update 2022
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: submission of surgical specimens to the anatomic pathology laboratory: relevance and indications - vascular, cardiovascular and thoracic surgery]
2022     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Effectiveness of non-pharmacological interventions aimed at commerce in controlling the spread of COVID-19]
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: submission of surgical specimens to the anatomic pathology laboratory: relevance and indications - otolaryngology and oral, maxillofacial and head and neck surgery]
2022     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Effectiveness of non-pharmacological interventions aimed at workplaces in controlling the spread of COVID-19]
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: submission of surgical specimens to the anatomic pathology laboratory: relevance and indications - eye surgery]
2022     Austrian Institute for Health Technology Assessment (AIHTA) Upper airway stimulation for moderate-to-severe sleep apnoea. Update 2022
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: revision of criteria for the withholding and termination of resuscitation by paramedics in prehospital setting]
2022     Austrian Institute for Health Technology Assessment (AIHTA) Subcutaneous implantable cardioverter-defibrillator (S-ICD). Update 2022
2022     Austrian Institute for Health Technology Assessment (AIHTA) CAR-T cell therapy: Contrasting the evidence from pivotal trials with the real world evidence (RWE)
2022     Austrian Institute for Health Technology Assessment (AIHTA) Percutaneous transvascular implantation of a coronary sinus reducing stent. Update 2022
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: solid organ transplantation – Section 3 - overview of renal and pancreatic transplantation in Québec]
2022     Canadian Agency for Drugs and Technologies in Health (CADTH) Rituximab for the treatment of primary membranous nephropathy
2022     Austrian Institute for Health Technology Assessment (AIHTA) Hepatic and portal vein embolisation prior to major hepatectomy
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: chronic obstructive pulmonary disease- detection, diagnosis, optimal use of medications and inhalation devices, and global management]
2022     Austrian Institute for Health Technology Assessment (AIHTA) Microwave ablation for liver tumours
2022     Austrian Institute for Health Technology Assessment (AIHTA) Osteopathy: effectiveness and safety for musculoskeletal pain and overview of training and quality requirements
2022     NIHR Health Technology Assessment programme Exercise to prevent shoulder conditions in patients undergoing breast cancer treatment. The PRevention Of Shoulder Problems Study (PROSPER)
2022     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal pharmacotherapy for transplant ineligible multiple myeloma
2022     Austrian Institute for Health Technology Assessment (AIHTA) His-bundle-pacing for patients requiring a permanent pacemaker or cardiac resynchronisation
2022     Austrian Institute for Health Technology Assessment (AIHTA) Chemosaturation with percutaneous hepatic perfusion for patients with liver cancer
2022     NIHR Health Technology Assessment programme SeHCAT (tauroselcholic [75selenium] acid) for the investigation of bile acid diarrhoea in adults: a systematic review and cost-effectiveness analysis
2022     Austrian Institute for Health Technology Assessment (AIHTA) Lower esophageal sphincter devices for laparoscopic surgery in patients with gastroesophageal reflux disease (GERD)
2022     Health Technology Wales (HTW) Convalescent plasma therapy for the treatment of COVID-19
2022     Belgian Health Care Knowledge Centre (KCE) Evaluation of Shingrix vaccine against herpes zoster
2022     Health Technology Wales (HTW) Extreme hypofractionated radiotherapy (EHFRT) for localised prostate cancer
2022     Austrian Institute for Health Technology Assessment (AIHTA) Child and adolescent mental health care models: a scoping review
2022     Austrian Institute for Health Technology Assessment (AIHTA) [Risk-based breast cancer screening in Austria: a systematic analysis of predictive models to assess individual breast cancer risk, their utility and applicability in a breast cancer screening programme]
2022     NIHR Health Technology Assessment programme Antibiotics for lower respiratory tract infection in children presenting in primary care (ARTIC PC)
2022     Health Technology Wales (HTW) Video laryngoscopes for use in pre-hospital care
2022     NIHR Health Technology Assessment programme Evaluation of the Healthy Start Voucher Scheme in UK: a natural experiment using the Growing Up in Scotland record linkage study and the Infant Feeding Survey
2022     Canadian Agency for Drugs and Technologies in Health (CADTH) Peer support programs for youth mental health
2022     NIHR Health Technology Assessment programme DexEnceph- Dexamethasone in Herpes Simplex Virus Encephalitis Randomised Controlled Trial and NonHSV Cohort Study
2022     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatment of adult patients with immune thrombocytopenia after failure of first-line therapies
2022     Canadian Agency for Drugs and Technologies in Health (CADTH) Internet-delivered cognitive behavioural therapy in the treatment of chronic non-cancer pain
2022     Canadian Agency for Drugs and Technologies in Health (CADTH) Intraocular lens implantation for infants with aphakia: a systematic review of clinical effectiveness and cost-effectiveness
2022     NIHR Health Technology Assessment programme The Best Services Trial (BeST?): Effectiveness and cost-effectiveness of the New Orleans Intervention Model for Infant Mental Health
2022     NIHR Health Technology Assessment programme Accuracy of a rapid intrapartum test for maternal group B streptococcal colonisation and its potential to reduce antibiotic usage in mothers with risk factors (GBS2)
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: integration of real-world data and evidence into assessments to support decision-making in the pharmaceutical sector]
2022     NIHR Health Technology Assessment programme Paclitaxel assisted balloon Angioplasty of Venous stenosis in haEmodialysis access: The PAVE Trial. A multicentre double-blind randomised controlled trial in haemodialysis patients with a stenosis in a native arteriovenous fistula
2022     NIHR Health Technology Assessment programme Assessing the efficacy and safety of methotrexate vs ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema in children Taskforce (TREAT) randomised controlled trial
2022     NIHR Health Technology Assessment programme Prospective randomised marker-based trial to assess the clinical utility and safety of biomarker-guided immunosuppression withdrawal in liver transplantation (LiverTOL-Dx Trial)
2022     NIHR Health Technology Assessment programme Unspecified living kidney donation in the UK: barriers to implementation and delivery
2022     Center for Evidence-based Practice (CEP) Workplace violence in healthcare settings
2022     NIHR Health Technology Assessment programme Delivering primary health care to homeless people: an evaluation of the integration, effectiveness and costs of different models
2022     Health Technology Wales (HTW) Electronic blood management systems for blood transfusions
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: evaluation of Synvisc and Synvisc One for the management of knee osteoarthritis]
2022     NIHR Health Technology Assessment programme The START (STrAtegies for RelaTives) study: a pragmatic randomised controlled trial to determine the effectiveness of a manual based coping strategy programme in promoting the mental health of carers of people with dementia - cohort follow-up
2022     NIHR Health Technology Assessment programme Coenzyme Q10 to manage chronic heart failure with a reduced ejection fraction: a systematic review and economic evaluation
2022     Health Technology Wales (HTW) Stereotactic ablative radiotherapy (SABR) for the treatment of renal cell carcinoma
2022     NIHR Health Technology Assessment programme Treatment of Barth Syndrome by CARDIOlipin MANipulation (CARDIOMAN): a randomised placebo-controlled pilot trial conducted by the nationally commissioned Barth Syndrome Service
2022     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Home enteral nutrition in older patients with severe protein-energy malnutrition after hip fracture]
2022     NIHR Health Technology Assessment programme Shock-absorbing flooring for fall-related injury prevention in older adults and staff in hospitals and care homes: the SAFEST systematic review
2022     NIHR Health Technology Assessment programme Endovascular stent grafting and open surgical replacement for chronic thoracic aortic aneurysms: a systematic review and prospective cohort study
2022     Scottish Health Technologies Group (SHTG) Closed loop systems and the artificial pancreas for type I diabetes mellitus (T1DM)
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: next-generation sequencing (NGS) panels for muscle disease]
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis by NAAT]
2022     Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS) [The use of social media and electronic communication in the delivery of youth protection services to young people in difficulty and their families]
2022     NIHR Health Services and Delivery Research programme Safety of disinvestment in mid- to late-term follow-up post primary hip and knee replacement: the UK SAFE evidence synthesis and recommendations
2022     Health Technology Wales (HTW) Laryngeal biopsies in the outpatient setting in people with suspected head and neck dysplasia/cancer
2022     NIHR Health Technology Assessment programme Biomarkers for assessing acute kidney injury for people who are being considered for admission to critical care: a systematic review and cost-effectiveness analysis
2022     NIHR Health Technology Assessment programme REVascularisation of Ischaemic VEntricular Dysfunction (REVIVED): a randomised comparison of percutaneous coronary intervention (with optimal medical therapy) vs. optimal medical therapy alone for heart failure secondary to coronary disease